SPP1 and hepatocellular carcinoma: Consistently, anti-SPP1 treatment enhanced anti-PD-1 efficacy by troubling SPP1+ macrophages-CAFs interaction, TIB formation and promoting CD8+ T infiltration in cancerous tissue, thereby highlighting future directions for therapeutic strategies which disrupt cell-cell communication in HCC [83].